Avid Bioservices Reports Net Income of $560 Thousand for Fiscal Year 2023

Avid Bioservices Inc.,(CDMO) a leading contract development and manufacturing organization (CDMO), has released its financial results for the fiscal year 2023, revealing a net income of $560 thousand and total revenue of $149.3 million. The company's performance reflects steady growth and highlights its position as a key player in the biopharmaceutical industry.

Financial Highlights

Avid Bioservices, Inc. has reported its consolidated financial statements for the fiscal year ended April 30, 2023. The company demonstrated a robust performance, achieving significant milestones in revenue and net income.

Revenue Growth